The WACC of Surgery Partners Inc (SGRY) is 7.2%.
Range | Selected | |
Cost of equity | 9.00% - 11.60% | 10.30% |
Tax rate | 17.80% - 49.30% | 33.55% |
Cost of debt | 7.00% - 7.50% | 7.25% |
WACC | 7.2% - 7.3% | 7.2% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.11 | 1.2 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 9.00% | 11.60% |
Tax rate | 17.80% | 49.30% |
Debt/Equity ratio | 1.23 | 1.23 |
Cost of debt | 7.00% | 7.50% |
After-tax WACC | 7.2% | 7.3% |
Selected WACC | 7.2% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for SGRY:
cost_of_equity (10.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.11) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.